New frontiers in contraceptive research : a blueprint for action
著者
書誌事項
New frontiers in contraceptive research : a blueprint for action
National Academies Press, c2004
- : pbk
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
内容説明・目次
内容説明
More than a quarter of pregnancies worldwide are unintended. Between 1995 and 2000, nearly 700,000 women died and many more experienced illness, injury, and disability as a result of unintended pregnancy. Children born from unplanned conception are at greater risk of low birth weight, of being abused, and of not receiving sufficient resources for healthy development. A wider range of contraceptive options is needed to address the changing needs of the populations of the world across the reproductive life cycle, but this unmet need has not been a major priority of the research community and pharmaceutical industry. New Frontiers in Contraceptive Research: A Blueprint for Action, a new report from the Institute of Medicine of the National Academies, identifies priority areas for research to develop new contraceptives. The report highlights new technologies and approaches to biomedical research, including genomics and proteomics, which hold particular promise for developing new products. It also identifies impediments to drug development that must be addressed. Research sponsors, both public and private, will find topics of interest among the recommendations, which are diverse but interconnected and important for improving the range of contraceptive products, their efficacy, and their acceptability.
Table of Contents
Front Matter
Executive Summary
1 Introduction
2 Target Discovery and Validation
3 Product Identification and Development
4 Improving Contraceptive Use and Acceptability
5 Capitalizing on Recent Scientific Advances
Appendix A: Examples of Progress and Impediments in Contraceptive
Research and Development
Appendix B: Agendas and Participants in Committee Workshops
Appendix C: Committee Biographies
Glossary
Acronyms
目次
- 1 Front Matter
- 2 Executive Summary
- 3 1 Introduction
- 4 2 Target Discovery and Validation
- 5 3 Product Identification and Development
- 6 4 Improving Contraceptive Use and Acceptability
- 7 5 Capitalizing on Recent Scientific Advances
- 8 Appendix A: Examples of Progress and Impediments in Contraceptive Research and Development
- 9 Appendix B: Agendas and Participants in Committee Workshops
- 10 Appendix C: Committee Biographies
- 11 Glossary
- 12 Acronyms
「Nielsen BookData」 より